Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Scribe Therapeutics Inc. (SCTX) had Non-Operating Income/Expense of $3.13M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.92M |
|
$-6.48M |
|
-- |
|
$1.92M |
|
$11.31M |
|
$-9.39M |
|
|
Non-Operating Income/Expense |
$3.13M |
$-6.26M |
|
$-6.26M |
|
$-6.48M |
|
$-6.48M |
|
$-6.48M |
|
$-6.48M |
|
$-9.39M |
|
$-9.39M |
|
2.48M |
|
2.48M |
|
$-2.62 |
|
$-2.62 |
|
| Balance Sheet Financials | |
$45.10M |
|
$5.75M |
|
$12.82M |
|
$57.93M |
|
$78.70M |
|
-- |
|
$23.72M |
|
$102.42M |
|
$-164.85M |
|
$-44.49M |
|
$-44.49M |
|
2.49M |
|
| Cash Flow Statement Financials | |
$-12.89M |
|
$37.47M |
|
$-1.79M |
|
$13.47M |
|
$36.26M |
|
$22.79M |
|
$2.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.57 |
|
-- |
|
-- |
|
-- |
|
-0.85 |
|
100.00% |
|
-489.83% |
|
-489.83% |
|
-- |
|
-326.64% |
|
-337.70% |
|
$-12.92M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
1.73 |
|
51.94 |
|
3.93% |
|
14.56% |
|
-11.18% |
|
14.56% |
|
$-17.90 |
|
$-5.22 |
|
$-5.21 |
|